David E. Lanfear, MD MS (@dlanfearMD) header
David E. Lanfear, MD MS (@dlanfearMD) profile picture

Vice President of Research and Chief Scientific Officer, Henry Ford Health. Co-director, Center for Individualized and Genomic Medicine Research

Joined October 2021
Photo by David E. Lanfear, MD MS (@dlanfearMD)Photo by David E. Lanfear, MD MS (@dlanfearMD)Photo by David E. Lanfear, MD MS (@dlanfearMD)Photo by David E. Lanfear, MD MS (@dlanfearMD)Photo by David E. Lanfear, MD MS (@dlanfearMD)Photo by David E. Lanfear, MD MS (@dlanfearMD)Photo by David E. Lanfear, MD MS (@dlanfearMD)Photo by David E. Lanfear, MD MS (@dlanfearMD)Photo by David E. Lanfear, MD MS (@dlanfearMD)
David E. Lanfear, MD MS retweeted
In heart failure, changes within the myocardium – the heart muscle – can disrupt oxygen delivery to cells, potentially contributing to further cardiac dysfunction and disease progression. Exploring this disruption, researchers developed a histology-image-based computational model to investigate how enlargement of the space between cardiac cells and reactive interstitial fibrosis affect oxygen delivery from capillaries. Their analysis found that both structural remodeling and fibrosis-related changes in tissue properties impaired oxygenation, with levels in heart muscle cells approximately 47% lower in severe fibrosis than in normal tissue. The balance between capillary area and interstitial area strongly predicted oxygenation, reflecting the combined effects of available supply and the distance oxygen must travel through tissue. Linking measurable structural features with cellular oxygen levels could ultimately help identify when impaired oxygenation may be contributing to worsening heart function, informing future approaches to heart failure treatment. 𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲: link.springer.com/article/10… 𝗦𝘁𝘂𝗱𝘆: Oxygen Transport Impairment in the Failing Heart: A Histology-Image-Based Computational Analysis 𝗔𝘂𝘁𝗵𝗼𝗿𝘀: Haifeng Wang, Mythri Tumbalam Gooty, @dlanfearMD, Hani N. Sabbah, and Lik-Chuan Lee @michiganstateu @MSU_EGR @HenryFordHealth 𝗦𝘂𝗯𝗺𝗶𝘁 𝘆𝗼𝘂𝗿 𝗺𝗮𝗻𝘂𝘀𝗰𝗿𝗶𝗽𝘁: link.springer.com/journal/10…
1
2
106
The most moving #presents I ever received came a few weeks ago: a pre-op spa day from my daughter so I could rock the OR table and post-surgical pillows from my son so I could recover in comfort. 1/
39
3
129
7,523
David E. Lanfear, MD MS retweeted
Heart Failure Awareness Week is here ❤️ From February 8–14, HFSA will be sharing trusted resources, practical tips, and easy-to-understand education focused on recognizing heart failure risk, understanding symptoms, and supporting heart health in everyday life. Whether patients are living with heart failure, caring for a loved one, or simply looking to learn more, this week is designed to inform, support, and empower. Encourage your patients to follow along!
7
7
396
David E. Lanfear, MD MS retweeted
Excited to share our new @NatRevCardiol review on the environmental #exposome in #HF risk and progression 🌍❤️ Led by @OmarHahad, this international collaboration connects pollution, climate, noise, light, metals, and the built environment with HF. shorturl.at/du0lb
1
13
1
36
3,513
David E. Lanfear, MD MS retweeted
Great kick off to #COMET-HF North American Investigator Meeting from @MyosinMD focused on the science behind omecamtiv mecarbil
1
2
11
817
A genetic variant in GRK4 significantly interacts with beta-blocker benefit in patients heart failure (and possibly other genetic variants as well): ascpt.onlinelibrary.wiley.co… @ASCPTjournals @dlanfearMD @Ana04524295 @pgrnhub @cpicpgx @pkpdpg @accpcardprn @GenPrecisionMed
2
9
347
David E. Lanfear, MD MS retweeted
Really happy to share our introductory guide to cardio-obstetrics in the CCU! We hope this will contribute to exceptional care for these patients @radcliffeCARDIO @AmitGoyalMD @AnnGageMD @KayleShapero
5
13
57
8,959
David E. Lanfear, MD MS retweeted
Exciting news! Our latest research on dilated cardiomyopathy has just been published in Nature Genetics: rdcu.be/d0ZzH A huge thank you to our incredible HERMES collaborators for making this possible. hermesconsortium.org @drjamesware @SeanLZheng @AH_AlbertHenry
2
8
984
David E. Lanfear, MD MS retweeted
Harnessing the Plasma Proteome to Predict Mortality in Heart Failure Subpopulations @JulioChirinosMd @dlanfearMD @DrNancySweitzer @fwasselbergs #AHAJournals ahajrnls.org/4ijStb7
6
10
1,380
David E. Lanfear, MD MS retweeted
🚨 Our latest GWAS of heart failure subtypes is now out in Nature Genetics! rdcu.be/eb9O0 A massive global collaboration from HERMES Consortium involving >40 studies with >150,000 heart failure cases. @HERMESgenetics @tomlumbers 🧵 highlighting key findings 1/
1
6
11
878
David E. Lanfear, MD MS retweeted
Congestion🚰 assessment in HF: from symptoms, to weights, BNP, invasive pressures....now IVC area? Check out this and other late breakers planned for @HFSA in @JCardFail ‼️ @NirUrielMD @gtsayer @FudimMarat @dranulala @robmentz @Stanford_HF sciencedirect.com/science/ar…
15
1
37
4,314
Exciting times: HFH+MSU Health Science Research Building ground breaking. Congrats to our great HFH leaders, @SteveKalkanisMD , Adnan Munkarah MD, Robert Riney, and all our MSU partners.
4
153
David E. Lanfear, MD MS retweeted
Happy birthday, 45🇺🇸 🔜47
414
2,202
44
53,469
766,560
Honored to be part of this fantastic randomized trial showing similar benefits of home-based cardiac rehab vs. traditional. Thanks to steve, clinton and the whole preventive cardiology crew for letting be a part. urldefense.com/v3/__https://…$
7
23
2,771
David E. Lanfear, MD MS retweeted
I’m proud to announce Dr. Jim Januzzi’s promotion to Chief Scientific Officer @BaimInstitute (formerly Harvard Clinical Research Institute or HCRI). BaimInstitute.org Dr. Januzzi is a brilliant clinical researcher and an academic superstar. His groundbreaking work in the field of biomarkers and congestive heart failure have earned him the respect and admiration of cardiologists around the world. His patients are fortunate to have him guiding their care @MGHMedicine which he will continue to do in his dual role. We value his tireless efforts and his dedication to Baim and its academic mission. We look forward to his contributions in shaping the academic and strategic vision of Baim in the years to come. Join me in congratulating Dr. Januzzi on his well deserved recognition and promotion!
55
34
11
414
56,864
Our turn! Today our PI is sharing latest findings in mitral valve disease biomarkers and omics at the #Biomarkers forum . Happy to share the floor with excellent speakers @ThomasThum_TH2 and @dlanfearMD in a brilliant session!
1
6
12
658
Outstanding work by Isabella Kardys, Marie de Bakker and friends, demonstrating proteomic derived panel outperforms clinical risk factors. academic.oup.com/ehjdh/artic…
2
313